Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat
Authors:
- 29 June 2005
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 182 (1) , 180-185
Abstract
Rationale It has been reported that each of three drugs effective in treating bipolar disorder (lithium, carbamazepine, and valproate) decreases the turnover of arachidonic acid (AA, 20:4n-6) in brain phospholipids of the awake rat. It is also known that lithium and carbamazepine do so without decreasing the turnover of docosahexaenoic acid (DHA, 22:6n-3). Objective The aim of this study was to see whether valproate also specifically targets the turnover of AA but not of DHA in brain phospholipids. Methods Valproate was administered (200 mg kg−1, i.p.) to rats for 30 days to produce a therapeutically relevant plasma concentration and then determine its effect compared with that of vehicle on incorporation and turnover rates of DHA in brain phospholipids. In unanesthetized rats that had received valproate or vehicle, [1-14C]DHA was infused intravenously, and arterial blood plasma was sampled until the animal was killed at 5 min; and its brain, after being microwaved, was subjected to chemical and radiotracer analysis. Results Using equations derived from our fatty acid model, it was found that chronic valproate compared with vehicle did not alter the rate of incorporation or turnover of DHA in brain phospholipids. Valproate-treated animals had higher concentrations of linoleic acid (18:2n-6) in several brain phospholipids, supporting the hypothesis that it alters brain n-6 fatty acid metabolism. Conclusions The results, comparable to published findings following chronic administration of lithium and carbamazepine to rats, support the hypothesis that drugs are effective against mania in bipolar disorder act by downregulating incorporation and turnover of AA, but not of DHA, in brain phospholipids.Keywords
This publication has 45 references indexed in Scilit:
- In vivoimaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammationJournal of Neurochemistry, 2004
- Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizersMolecular Psychiatry, 2004
- ResolvinsJournal of Experimental Medicine, 2002
- A common mechanism of action for three mood-stabilizing drugsNature, 2002
- Effect of valproate on the metabolism of the central nervous systemLife Sciences, 1997
- Specific Activity of Brain Palmitoyl‐CoA Pool Provides Rates of Incorporation of Palmitate in Brain Phospholipids in Awake RatsJournal of Neurochemistry, 1995
- Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brainNeurochemical Research, 1993
- Valproyl CoA: An active metabolite of valproate?Medical Hypotheses, 1990
- Intravenous injection of [1‐14C]arachidonate to examine regional brain lipid metabolism in unanesthetized ratsJournal of Neuroscience Research, 1989
- Quantitative analysis of simple lipid classes by thin-layer chromatographyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968